An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription
- PMID: 1710341
- PMCID: PMC328182
- DOI: 10.1093/nar/19.10.2645
An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription
Abstract
The endothelial leukocyte adhesion molecule 1 (ELAM-1) is transiently expressed specifically on the surface of cytokine-induced endothelial cells. We demonstrate that the transient expression of the protein is paralleled by an increase and decrease in transcription of the ELAM-1 gene. To identify the cis-acting transcription control regions within the ELAM-1 gene that are responsible for this cytokine-induced expression, we isolated and analyzed an ELAM-1 genomic clone containing sequences upstream of the transcription start site. We constructed a series of ELAM-1 deletion mutants linked to a reporter gene and analyzed their expression in both endothelial and non-endothelial cells. Results show that a fragment of 233 bp upstream of the transcription start site is sufficient to confer cytokine inducibility upon the reporter gene in both endothelial and non-endothelial cells. Further analysis defined two elements within this region that are involved in the cytokine inducibility of the ELAM-1 gene. One element lies within the -233 to -117 region, the other element represents an NF kappa B consensus binding site between nucleotides -94 to -85. Gel shift analysis reveals increased binding of an NF kappa B-like factor to this consensus sequence in extracts prepared from IL-1-induced endothelial cells. The results suggest that cytokine induction of ELAM-1 gene transcription is imparted by a combination of positive factors, one being an NF kappa B-like transcription factor, interacting with cis-acting elements within the enhancer/promoter of the gene.
Similar articles
-
Activation of endothelial-leukocyte adhesion molecule 1 (ELAM-1) gene transcription.Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6523-7. doi: 10.1073/pnas.88.15.6523. Proc Natl Acad Sci U S A. 1991. PMID: 1713680 Free PMC article.
-
Murine endothelial leukocyte-adhesion molecule 1 is a close structural and functional homologue of the human protein.Eur J Biochem. 1992 Jun 1;206(2):401-11. doi: 10.1111/j.1432-1033.1992.tb16940.x. Eur J Biochem. 1992. PMID: 1375914
-
Three NF-kappa B binding sites in the human E-selectin gene required for maximal tumor necrosis factor alpha-induced expression.Mol Cell Biol. 1994 Sep;14(9):5820-31. doi: 10.1128/mcb.14.9.5820-5831.1994. Mol Cell Biol. 1994. PMID: 7520526 Free PMC article.
-
Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers.FASEB J. 1995 Jul;9(10):899-909. FASEB J. 1995. PMID: 7542214 Review.
-
Transcriptional regulation of endothelial cell adhesion molecules: a dominant role for NF-kappa B.Agents Actions Suppl. 1995;47:135-41. doi: 10.1007/978-3-0348-7343-7_12. Agents Actions Suppl. 1995. PMID: 7540353 Review.
Cited by
-
Induction of the E-selectin promoter by interleukin 1 and tumour necrosis factor alpha, and inhibition by glucocorticoids.Biochem J. 1997 Dec 1;328 ( Pt 2)(Pt 2):707-15. doi: 10.1042/bj3280707. Biochem J. 1997. PMID: 9371735 Free PMC article.
-
Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells.Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):9887-91. doi: 10.1073/pnas.90.21.9887. Proc Natl Acad Sci U S A. 1993. PMID: 7694295 Free PMC article.
-
Inhibition of bovine endothelial cell activation in vitro by regulated expression of a transdominant inhibitor of NF-kappa B.J Clin Invest. 1997 Feb 15;99(4):763-72. doi: 10.1172/JCI119222. J Clin Invest. 1997. PMID: 9045881 Free PMC article.
-
A tale of two proteins: PACT and PKR and their roles in inflammation.FEBS J. 2021 Nov;288(22):6365-6391. doi: 10.1111/febs.15691. Epub 2021 Jan 15. FEBS J. 2021. PMID: 33387379 Free PMC article. Review.
-
Wnt/β-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma.Front Oncol. 2025 Feb 14;14:1456959. doi: 10.3389/fonc.2024.1456959. eCollection 2024. Front Oncol. 2025. PMID: 40028002 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases